Cita APA (7a ed.)
Zhou, C., Greillier, L., Liu, G., John, T., Xing, L., Kowalski, D., . . . Hong, Q. (2026). First-Line Sunvozertinib in NSCLC with EGFR Exon 20 Insertion Mutations. New England Journal of Medicine, 395(8), 756-767.
Cita Chicago Style (17a ed.)
Zhou, Caicun, et al. "First-Line Sunvozertinib in NSCLC with EGFR Exon 20 Insertion Mutations." New England Journal of Medicine 395, no. 8 (2026): 756-767.
Cita MLA (9a ed.)
Zhou, Caicun, et al. "First-Line Sunvozertinib in NSCLC with EGFR Exon 20 Insertion Mutations." New England Journal of Medicine, vol. 395, no. 8, 2026, pp. 756-767.
Precaución: Estas citas no son 100% exactas.